2026 Global: Cataract Surgery Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Cataract Surgery Devices Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cataract surgery devices market by geography and historical trend. The scope of the report extends to sizing of the cataract surgery devices market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Alcon, Johnson & Johnson (Vision), Carl Zeiss Meditec, Bausch + Lomb, NIDEK, STAAR Surgical, HOYA (including Rayner/ZEISS partnerships), EssilorLuxottica, Glaukos, and RxSight are widely recognized as ten major companies competing across the global cataract surgery devices market. Alcon is a market leader with a broad portfolio spanning phacoemulsification systems, intraocular lenses (IOLs) and surgical consumables and continues to expand through technology refinements and IOL innovations that target premium refractive outcomes. Johnson & Johnson’s Vision business (including its Tecnis IOL line and surgical platforms) leverages strong surgeon relationships and an extensive IOL product range to capture large shares of premium and routine cataract procedures. Carl Zeiss Meditec supplies advanced diagnostic and surgical equipment—biometry devices, microscopes and femtosecond/cataract lasers—that integrate with IOL planning workflows to improve refractive predictability. Bausch + Lomb offers a complementary mix of IOLs, viscoelastics and surgical instruments with a long-standing global footprint and R&D emphasis on materials and optics for better visual outcomes. NIDEK provides ophthalmic lasers, phaco systems and diagnostic instrumentation that support surgeons from preoperative measurement through treatment, strengthening clinical workflows in many surgical centers.
STAAR Surgical is notable for its specialty implantable lenses and niche refractive phakic IOL technologies that address high-refractive-error patients and cases where corneal-based solutions are unsuitable. HOYA, through its surgical optics businesses and strategic acquisitions/partnerships in the IOL space (and including Rayner in some markets), competes on optical design and lens materials aimed at reducing dysphotopsia while improving contrast and patient satisfaction. EssilorLuxottica’s involvement—primarily via lens technology, optical science and distribution strength—complements the market by shaping postoperative refractive expectations and optical benchmarking for IOL designers. Glaukos, while best known for glaucoma microinvasive devices, increasingly intersects with cataract surgery by offering MIGS implants and combined-procedure strategies that influence surgical decision-making and device bundling in the anterior segment. RxSight’s Light Adjustable Lens system represents a disruptive niche within IOLs by allowing postoperative noninvasive refractive customization with UV light to refine outcomes after implantation, creating a distinct value proposition for surgeons and patients seeking personalization.
Collectively these companies drive the market through diversified strategies: incremental device improvements (phaco platforms, viscoelastics), advanced optics and materials for IOLs, integration of diagnostic-to-surgical workflows (biometry and femtosecond lasers), and adjunctive technologies such as adjustable IOLs and MIGS that reshape procedure planning and patient expectations. Geographical reach, surgeon training programs, OEM partnerships, and acquisitions further determine competitive positions, while ongoing R&D into biomaterials, optics and automation continues to define product differentiation and future growth opportunities within the cataract surgery devices market.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cataract surgery devices market by geography and historical trend. The scope of the report extends to sizing of the cataract surgery devices market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Alcon, Johnson & Johnson (Vision), Carl Zeiss Meditec, Bausch + Lomb, NIDEK, STAAR Surgical, HOYA (including Rayner/ZEISS partnerships), EssilorLuxottica, Glaukos, and RxSight are widely recognized as ten major companies competing across the global cataract surgery devices market. Alcon is a market leader with a broad portfolio spanning phacoemulsification systems, intraocular lenses (IOLs) and surgical consumables and continues to expand through technology refinements and IOL innovations that target premium refractive outcomes. Johnson & Johnson’s Vision business (including its Tecnis IOL line and surgical platforms) leverages strong surgeon relationships and an extensive IOL product range to capture large shares of premium and routine cataract procedures. Carl Zeiss Meditec supplies advanced diagnostic and surgical equipment—biometry devices, microscopes and femtosecond/cataract lasers—that integrate with IOL planning workflows to improve refractive predictability. Bausch + Lomb offers a complementary mix of IOLs, viscoelastics and surgical instruments with a long-standing global footprint and R&D emphasis on materials and optics for better visual outcomes. NIDEK provides ophthalmic lasers, phaco systems and diagnostic instrumentation that support surgeons from preoperative measurement through treatment, strengthening clinical workflows in many surgical centers.
STAAR Surgical is notable for its specialty implantable lenses and niche refractive phakic IOL technologies that address high-refractive-error patients and cases where corneal-based solutions are unsuitable. HOYA, through its surgical optics businesses and strategic acquisitions/partnerships in the IOL space (and including Rayner in some markets), competes on optical design and lens materials aimed at reducing dysphotopsia while improving contrast and patient satisfaction. EssilorLuxottica’s involvement—primarily via lens technology, optical science and distribution strength—complements the market by shaping postoperative refractive expectations and optical benchmarking for IOL designers. Glaukos, while best known for glaucoma microinvasive devices, increasingly intersects with cataract surgery by offering MIGS implants and combined-procedure strategies that influence surgical decision-making and device bundling in the anterior segment. RxSight’s Light Adjustable Lens system represents a disruptive niche within IOLs by allowing postoperative noninvasive refractive customization with UV light to refine outcomes after implantation, creating a distinct value proposition for surgeons and patients seeking personalization.
Collectively these companies drive the market through diversified strategies: incremental device improvements (phaco platforms, viscoelastics), advanced optics and materials for IOLs, integration of diagnostic-to-surgical workflows (biometry and femtosecond lasers), and adjunctive technologies such as adjustable IOLs and MIGS that reshape procedure planning and patient expectations. Geographical reach, surgeon training programs, OEM partnerships, and acquisitions further determine competitive positions, while ongoing R&D into biomaterials, optics and automation continues to define product differentiation and future growth opportunities within the cataract surgery devices market.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.